Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta. The FDA approved low-dose, preservative-free Qlosi (pilocarpine HCl ophthalmic solution) 0.4% in October 2023 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback